Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Taiho Oncology, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
SK Life Science, Inc.
ABM Therapeutics Corporation
ABM Therapeutics Corporation
Cambridge University Hospitals NHS Foundation Trust
Tocagen Inc.
AbbVie